DJIA 17,778.15 421.28 2.43%
NASDAQ 4,748.40 104.08 2.24%
S&P 500 2,061.23 48.34 2.40%
market minute promo

Medivation, Inc. (NASDAQ: MDVN)

109.17 2.55 (2.39%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MDVN $109.17 2.39%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $108.32
Previous Close $106.62
Daily Range $106.30 - $109.17
52-Week Range $54.37 - $117.23
Market Cap $8.5B
P/E Ratio 75.08
Dividend (Yield) $0.00 (0.0%)
Volume 855,944
Average Daily Volume 1,121,375
Current FY EPS $2.56

Sector

Healthcare

Industry

Drugs

Medivation, Inc. (MDVN) Description

A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies. Website: http://www.medivation.net/

News & Commentary Rss Feed

Top Healthcare Stocks for 2014

These 10 stocks were the top large-cap performers in healthcare during 2014.

Medivation Poised To Expand As Xtandi Shows Efficacy In Advanced Triple Negative Breast Cancer

Astellas-Medivation Reveal Data on Xtandi for Breast Cancer - Analyst Blog

5 Biotech Stocks to Buy for 2015

These five biotech stocks may have what it takes to reward investors next year.

This Could Be the Next Big Pharma Buyout

Three Motley Fool analysts tell investors which three companies they think would be ripe for an acquisition.

MDVN January 2015 Options Begin Trading

Medivation (MDVN) Reaches New Lifetime High Today

Two mini flash crashes rock stock market

MDVN January 2017 Options Begin Trading

Should Johnson & Johnson Buy Medivation Inc.?

Johnson & Johnson's top-selling prostate cancer treatment is facing a stiff challenger in Medivation's Xtandi, but an acquisition may not be in the cards.

See More MDVN News...

MDVN's Top Competitors

MDVN $109.17 (2.39%)
Current stock: MDVN
TMO $127.52 (2.20%)
Current stock: TMO
ILMN $187.29 (3.36%)
Current stock: ILMN
WAT $114.26 (0.80%)
Current stock: WAT